Exercise and heart rhythm study for ARVC patients
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at how exercise affects heart rhythm in people with ARVC, a genetic heart condition. Participation involves supervised exercise sessions and heart monitoring to better understand safe activity levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of ARVC (arrhythmogenic right ventricular cardiomyopathy).
- You have a specific genetic change (in PKP-2, DSG-2, or DSP genes) or have had genetic testing that found no clear cause.
- You are over 14 years old and have a BMI between 18.5 and 39.9.
- You have not fainted or had a cardiac arrest during exercise in the last 6 months.
- If you have a defibrillator (ICD) and take heart medications, you may still be eligible.
- You agree to avoid exercise, caffeine, and alcohol before test days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how plakophilin 2 (PKP2)-related arrhythmogenic right ventricular cardiomyopathy (ARVC) progresses over time. You'll give blood samples to check for antibodies to a virus used in gene therapy, and help doctors understand the disease better.
This trial tests a new gene therapy called TN-401 for people with ARVC caused by a specific PKP2 gene mutation. The goal is to see if the treatment is safe and can help reduce dangerous heart rhythms.
This study uses a special type of heart scan (FAPI PET/CT) to better visualize and understand arrhythmogenic right ventricular cardiomyopathy (ARVC), a condition where the heart muscle weakens and causes irregular heartbeats. The scan may help doctors understand the disease better and improve patient care.
This study looks at whether a supervised exercise and rehabilitation program can help people who have a genetic heart condition called arrhythmogenic cardiomyopathy. The program is designed to be safe for people with a higher genetic risk and aims to improve overall heart health.
This study is a registry that collects information from people with arrhythmogenic cardiomyopathy who have an ICD. The goal is to learn more about the condition, its heart rhythm complications, and how the ICD works, which may help improve future care.
This study looks at how the heart's electrical signals can help doctors understand if treatments prevent dangerous heart rhythms in active people. It involves people with or without heart devices like ICDs or pacemakers, and may help improve care for active individuals with heart conditions.
Hear when a new Arrhythmogenic Right Ventricular Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.